Behzad Aghazadeh's Net Worth
$0
Who is Behzad Aghazadeh?
Behzad Aghazadeh does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Mirati Therapeutics, Inc., CymaBay Therapeutics, Inc., and Aadi Bioscience, Inc..
SEC CIK
Behzad Aghazadeh's CIK is 0001701815
Past Insider Trading and Trends
2019 was Behzad Aghazadeh's most active year for acquiring shares with 3 total transactions. Behzad Aghazadeh's most active month to acquire stocks was the month of May. 2020 was Behzad Aghazadeh's most active year for disposing of shares, totalling 3 transactions. Behzad Aghazadeh's most active month to dispose stocks was the month of September. 2019 saw Behzad Aghazadeh paying a total of $0.00 for 176,744 shares, this is the most they've acquired in one year. In 2020 Behzad Aghazadeh cashed out on 319,848 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
InvestorBehzad Aghazadeh owns 100,000 units of Common Stock, $0.01 par value per share, 17,234 units of Common Stock, $0.01 par value per share (''Common Stock''). Behzad Aghazadeh used to own units in Common Stock but no longer holds any shares there. In the year 2017 Behzad Aghazadeh filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.26M |
—
|
—
|
0
|
Oct 23
| |||
Form 4
| +27.51% | 3.72K |
—
|
—
| 17.23K |
Jun 18
| |||
Form 4
| +7.14% | 1.75M |
$28.50 | $49,875,000.00 | 26.25M |
May 1
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Mar 20
| |||
Form 4
| +8.89% | 2M |
$17.50 | $35,000,000.00 | 24.5M |
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
| +3.49% | 1.5M |
$13.67 | $20,280,000.00 | 44.5M |
Oct 2 - Oct 3
| |||
Form 4
| +2.48% | 1M |
$13.50 | $13,548,000.00 | 41.4M |
Jun 26 - Jun 28
| |||
Form 4
| +251.16% | 9.67K |
—
|
—
| 13.52K |
Jun 7
| |||
Form 4
| +4.07% | 1.54M |
$12.21 | $18,743,220.41 | 39.25M |
Jun 3 - Jun 5
| |||
Form 4
| +2.09% | 750K |
$15.13 | $11,328,750.00 | 36.68M |
May 13 - May 15
| |||
Form 4
|
∞
| 3.85K |
—
|
—
| 3.85K |
Apr 2
| |||
Form 4
| +1.14% | 200K |
$23.39 | $4,678,000.00 | 17.71M |
Jun 15
| |||
Form 4
| +3.39% | 575K |
$24.00 | $13,800,000.00 | 17.51M |
Jun 15
| |||
Form 4
| +5.45% | 875K |
$7.00 | $6,125,000.00 | 16.94M |
Feb 16
| |||
Form 4
| +4.33% | 1.32M |
$10.68 | $13,868,250.00 | 31.95M |
Nov 14 - Nov 15
| |||
Form 4
| +40.54% | 4.25M |
—
|
—
| 14.74M |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21 - Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.62% | -62.50K |
$101.88 | -$6,367,500.00 | 3.8M |
Jul 23
| |||
Form 4
| -3.07% | -248.78K |
$74.93 | -$18,643,006.80 | 7.85M |
Mar 18 - Mar 20
| |||
Form 4
| -14.31% | -686.82K |
$73.00 | -$50,137,860.00 | 4.11M |
Feb 20
| |||
Form 4
| +9.09% | 400K |
$38.85 | $15,540,000.00 | 4.8M |
Jun 11
| |||
Form 4
| +8.52% | 687.5K |
$10.43 | $8,744,750.00 | 8.76M |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CymaBay Therapeutics, Inc. (CBAY) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12 - Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +56.97% | 1.26M |
$12.50 | $15,750,000.00 | 3.47M |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +637.25% | 1.91M |
$13.08 | $24,999,980.90 | 2.21M |
Aug 26 - Aug 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||